W. Küng
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
-
- HER2/EGFR in Cancer Research
- Drug Transport and Resistance Mechanisms
Papers in
-
- Gene expression and cancer classification 2
- Protein Kinase Regulation and GTPase Signaling 2
- Molecular Biology Techniques and Applications 2
- Muscle Physiology and Disorders 2
- PI3K/AKT/mTOR signaling in cancer 2
- Genetics 8
- Estrogen and related hormone effects 8
- Co-authors
- Urs Eppenberger (15 shared papers)W. J. Richter (1 shared paper)H.‐P. KRIEMLER (1 shared paper)J. W. Faigle (1 shared paper)H. Stierlin (1 shared paper)T. WINKLER (1 shared paper)A. Sallmann (1 shared paper)Serban Dan Costa (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Developmental Cell (2 papers)FEBS Letters (2 papers)Recent results in cancer research (2 papers)The International Journal of Biological Markers (2 papers)
- Partner nations
- SwitzerlandFranceHong Kong
In The Last Decade
W. Küng
18 papers receiving 386 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 84
- Pharmacology 79
- Oncology 118
- Analytical Chemistry 29
- Molecular Biology 196
Countries citing papers authored by W. Küng
This map shows the geographic impact of W. Küng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Küng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Küng more than expected).
Fields of papers citing papers by W. Küng
This network shows the impact of papers produced by W. Küng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Küng. The network helps show where W. Küng may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Küng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 162 | |
| 2 | 1986 | 90 | |
| 3 | 1978 | 35 | |
| 4 | 1977 | 23 | |
| 5 | 2023 | 16 | |
| 6 | 2006 | 13 | |
| 7 | 1988 | 12 | |
| 8 | Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors. | 1980 | 12 |
| 9 | 2006 | 11 | |
| 10 | 1977 | 10 | |
| 11 | 1983 | 10 | |
| 12 | 2024 | 8 | |
| 13 | 1979 | 5 | |
| 14 | 1988 | 4 | |
| 15 | 1994 | 3 | |
| 16 | 1989 | 2 | |
| 17 | 1984 | 2 | |
| 18 | Correlation of estrogen receptors and charge alterations of regulatory subunits of cAMP-dependent protein kinases in human mammary tumor cells. | 1984 | 1 |
About W. Küng
W. Küng is a scholar working on Molecular Biology, Genetics, Oncology, Toxicology and Pharmacology, having authored 18 papers that have together received 419 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (8 papers), Gene expression and cancer classification (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Molecular Biology Techniques and Applications (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Muscle Physiology and Disorders (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Pharmacology (84 citations), Pharmacology (79 citations), Oncology (118 citations), Analytical Chemistry (29 citations) and Molecular Biology (196 citations). W. Küng has collaborated with scholars based in Switzerland, France and Hong Kong. Frequent co-authors include Urs Eppenberger, W. J. Richter, H.‐P. KRIEMLER, J. W. Faigle, H. Stierlin, T. WINKLER, A. Sallmann, Serban Dan Costa, W Roos and Doriano Fabbro. Their work appears in journals such as Biochemical and Biophysical Research Communications, Developmental Cell, FEBS Letters, Recent results in cancer research and The International Journal of Biological Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.